$37.07 +0.12 (%) Mylan N.V. - NASDAQ

Jan. 20, 2017 | 04:00 PM

Headlines

  1. Quotes

  2. Charts

  3. Analysis

  4. Options

  5. Historical



Partner Headlines

  1. T Minus One

    TalkMarkets | Jan. 19, 2017 | 23:18PM EST
  2. Mallinckrodt Rebounds After FTC Probe; Doubts Rival Will Get FDA Nod

    Investors Business Daily | Jan. 19, 2017 | 12:06PM EST
  3. Trump + Stocks: The Week In Review

    TalkMarkets | Jan. 13, 2017 | 19:44PM EST
  4. Drug Stocks Tank As Trump Vows To Attack High Drug Prices

    Investors Business Daily | Jan. 11, 2017 | 16:21PM EST
  5. Drug Stocks Tank As Trump Vows To Attack High Drug Prices

    Investors Business Daily | Jan. 11, 2017 | 13:48PM EST
  6. Celgene CEO: Drug-Pricing Debate Hinges On Incentives For Innovation

    Investors Business Daily | Jan. 10, 2017 | 13:26PM EST
  7. Mylan, Novartis, Hikma Take On GSK In Generic Asthma Battle

    Investors Business Daily | Jan. 5, 2017 | 13:31PM EST
  8. Cempra Plunges To 52-Week Low, Shire Drug Label Expanded

    TalkMarkets | Dec. 30, 2016 | 10:33AM EST
  9. Stock Futures Flat To Higher; Early Risers Nike, Mylan, Nvidia

    Investors Business Daily | Dec. 30, 2016 | 08:02AM EST
  10. Allergan Outlook Improves On Good Trial For Colon Drug: Credit Suisse

    Investors Business Daily | Dec. 23, 2016 | 10:11AM EST
  11. Allergan Outlook Improves On Good Trial For Colon Drug: Credit Suisse

    Investors Business Daily | Dec. 23, 2016 | 10:11AM EST
  12. Drastic Drug-Price Action No Trump Card, Says Needham

    Investors Business Daily | Dec. 22, 2016 | 11:24AM EST
  13. Mylan Launching Cheaper EpiPen Generic Amid Drug Pricing Saga

    Investors Business Daily | Dec. 16, 2016 | 13:15PM EST
  14. Mylan, Teva Among 6 Pharmas Sued In Alleged Price-Fixing Scheme

    Investors Business Daily | Dec. 15, 2016 | 13:02PM EST
  15. DOJ Charges Pharma Execs With Price-Fixing; Teva, Mylan Stocks Fall

    Investors Business Daily | Dec. 14, 2016 | 15:22PM EST
  16. Week In Review: Trump Talks, Stocks Hits High, Amazon Is A Go

    Investors Business Daily | Dec. 9, 2016 | 10:40AM EST
  17. Allergan Slides After Mylan Granted Request For Review Of Restasis Patent

    TalkMarkets | Dec. 8, 2016 | 18:13PM EST
  18. Mylan Slumps After Disclosing Plans To Cut Workforce In Restructuring

    TalkMarkets | Dec. 7, 2016 | 13:12PM EST
  19. Mylan Nose-Dives On Plan To Slash 10% Of Workforce Following M&A

    Investors Business Daily | Dec. 7, 2016 | 13:11PM EST
  20. Drug Stocks Topple On Donald Trump's Pledge To Bring Down Drug Prices

    Investors Business Daily | Dec. 7, 2016 | 11:36AM EST
  21. Drug Stocks Topple On Donald Trump's Pledge To Bring Down Drug Prices

    Investors Business Daily | Dec. 7, 2016 | 11:36AM EST
  22. Trump Targets Drug Prices, Apple, Seeks '5 Minutes' With Offshoring Firms

    Investors Business Daily | Dec. 7, 2016 | 10:52AM EST
  23. 6 Things You Need To Know About Teva's Q3 Earnings

    TalkMarkets | Nov. 16, 2016 | 13:15PM EST
  24. Transitioning

    TalkMarkets | Nov. 10, 2016 | 23:56PM EST
  25. Morning Call For Thursday, Nov. 10

    TalkMarkets | Nov. 10, 2016 | 09:03AM EST
  26. Pharmaceutical Stocks Surge After Republican Victory

    TalkMarkets | Nov. 9, 2016 | 12:48PM EST
  27. 5 Stocks to Watch After the Market Closes Today - Wednesday, Nov. 9

    TalkMarkets | Nov. 9, 2016 | 10:09AM EST
  28. On The Fly: After Hours Movers - 11/8

    TalkMarkets | Nov. 8, 2016 | 02:44AM EST
  29. Pricing Issues Continue To Weigh On The Pharma Sector

    TalkMarkets | Nov. 5, 2016 | 20:01PM EST
  30. Generic Drugs Probe Seen As Possible 'Severe' Sector Overhang

    TalkMarkets | Nov. 4, 2016 | 13:40PM EST
  31. S&P 500 Index Posted Its 8th Consecutive Loss

    TalkMarkets | Nov. 4, 2016 | 00:30AM EST
  32. 3Q Earnings And Political Uncertainty

    TalkMarkets | Oct. 10, 2016 | 20:24PM EST
  33. Dow Jones Industrial Average Today Climbs As Oil Prices Surge

    TalkMarkets | Oct. 10, 2016 | 19:14PM EST
  34. Mylan Rises After Signing EpiPen Settlement With DOJ

    TalkMarkets | Oct. 10, 2016 | 15:16PM EST
  35. Mylan Rises After Signing EpiPen Settlement With DOJ

    TalkMarkets | Oct. 10, 2016 | 15:16PM EST
  36. Clarifying Confusion Over Mylan's EpiPen Profits

    TalkMarkets | Oct. 9, 2016 | 01:27AM EST
  37. Biotech Stocks Recovering From Last Week’s Free Fall

    TalkMarkets | Oct. 5, 2016 | 23:06PM EST
  38. Time For Congress To Stop Hollering At CEOs And Take Action

    TalkMarkets | Sep. 25, 2016 | 19:12PM EST
  39. Mylan - Should This Stock Be In Your Portfolio?

    TalkMarkets | Sep. 25, 2016 | 03:03AM EST
  40. Wells Fargo And Mylan: Corporate Devils Or Unworthy Scapegoats?

    TalkMarkets | Sep. 23, 2016 | 18:00PM EST
  41. Wells Fargo And Mylan: Corporate Devils Or Scapegoats?

    TalkMarkets | Sep. 23, 2016 | 18:00PM EST
  42. David Einhorn's Top 5 New Q4 Buys

    GuruFocus | Feb. 16, 2016 | 18:51PM EST
  43. Benzinga's M&A Chatter for Wednesday February 10, 2016

    Benzinga | Feb. 10, 2016 | 21:59PM EST
  44. Mylan Will Buy Meda For $9.9 Billion, Q4 Earnings Miss; Stock Dives

    IBD | Feb. 10, 2016 | 17:30PM EST
  45. David Einhorn Rebounds - Somewhat

    GuruFocus | Feb. 9, 2016 | 16:12PM EST
  46. David Einhorn Comments on Mylan

    GuruFocus | Jan. 19, 2016 | 17:32PM EST
  47. Mylan, Momenta Team Up To Develop Biosimilar Drugs

    IBD | Jan. 8, 2016 | 15:34PM EST
  48. Clinton To Target 'Inversions' With Exit Tax

    FoxBusiness | Dec. 9, 2015 | 14:41PM EST
  49. Pfizer-Allergan Won't Be the Last Inversion

    FoxBusiness | Nov. 23, 2015 | 12:26PM EST
  50. Glenview's Larry Robbins Lowers Drug Manufacturers, Raises Health Care Providers

    GuruFocus | Nov. 20, 2015 | 18:26PM EST
Trading Center